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Over the past decade, aminoacyl-tRNA synthetases (AARSs) have emerged as a new class of regulatory pro-
teins with widespread functions beyond their classic role in protein synthesis. The functional expansion con-
curs with the incorporation of new domains and motifs to AARSs and coincides with the emergence of the
multi-synthetase complex (MSC) during the course of eukaryotic evolution. Notably, the new domains in
AARSs are often found to be structurally disordered or to be linked to the enzyme cores via unstructured
linkers. We performed bioinformatic analysis and classified the 20 human cytoplasmic AARSs into three
groups based on their propensities for structural disorder. The analysis also suggests that, while the assem-
bly of the MSCmainly involves ordered structural domains, structurally disordered regions play an important
role in activating and expanding the regulatory functions of AARSs.An ordered protein structure has a defined three-dimensional
(3D) architecture composed of secondary structurally elements,
such as a helices and b strands, arranged in a certain manner. In
contrast, disordered proteins or regions lack a well-defined
structure and exist as dynamic conformational ensembles.
Although structural disorders are common in various proteomes,
their frequency increases with increasing complexity of the
organisms. For example, Ward and colleagues predicted that
long (>30 residues) disordered segments occur in 2.0% of
archaeal, 4.2% of eubacterial, and 33.0% of eukaryotic proteins
(Ward et al., 2004). Genome-scale bioinformatics analyses have
shown that structural disorder is most common in proteins
involved in signal transduction, transcription, and translation
regulation due to the ability of the structural disorder to offer
the malleability and adaptability required in signaling and regula-
tion (Tantos et al., 2012). A prominent example is the p53 protein,
which interacts with many other proteins to carry out its signal
transduction function. Most of these interactions are mediated
by regions on p53 that are intrinsically disordered, for example,
the C terminus, which, upon interaction with different partners,
adopts completely different structures (Oldfield et al., 2008). In
contrast, catalysis is often performed by a globular protein,
where a well-defined conformation or active site geometry is a
prerequisite for enzymatic function.
Aminoacyl-tRNA synthetases (AARSs) are multifunctional pro-
teins possessing both enzymatic and regulatory functions.
Members of the AARS family catalyze the first reaction in protein
synthesis, that is, to ligate an amino acid to the 30-end of its
cognate tRNA by using the energy released from hydrolyzing
ATP. Importantly, it is the AARS-catalyzed aminoacylation reac-
tion that has established the rules of the genetic code by pairing
each amino acid with a tRNA harboring the cognate anticodon
trinucleotide. Therefore, tRNA synthetase is considered to be
one of the most ancient protein families and is essential in all
three domains of life (Woese et al., 2000). While preserving this
enzymatic role, eukaryotic AARSs develop other functions dur-
ing the course of evolution. Human cytoplasmic tRNA synthe-Chemistry & Biology 2tases, in particular, regulate diverse functions in different path-
ways including angiogenesis, inflammation, development and
tumorigenesis. Thus, AARSs have emerged as a new class of
regulatory proteins with widespread functions beyond their
classic role in protein synthesis. The goal of this paper is to pro-
pose that structural disorder plays an important role in expand-
ing the functionome of AARSs.
New Domains of AARSs and the Multi-Synthetase
Complex
Comparing the protein sequences of eukaryotic cytoplasmic
AARSs with their bacterial and archaeal counterparts, it is imme-
diately obvious that eukaryotic AARSs are generally larger. The
size increase is mainly due to the acquisition of new domains
or motifs at either N or C terminus, and the acquisition continues
during the evolution of higher eukaryotes (Guo et al., 2010a).
Albeit with some exceptions, these new domains are in general
dispensable for the aminoacylation function of the synthetases
and, instead, are intimately associated with developing regulato-
ry functions of AARSs.
Also associated with the acquisition of new domains is the
emergence of a multi-synthetase complex (MSC) in eukaryotes.
A miniature MSC, composed of MetRS, GluRS, and a nonsyn-
thetase protein Arc1p, appears in basal eukaryotes such as
Saccharomyces cerevisiae. From Drosophila to mammals, the
MSC contains nine AARS components (LysRS, ArgRS, GlnRS,
AspRS, MetRS, IleRS, LeuRS, and a bifunctional GluProRS)
and three accessory proteins (p43/AIMP1, p38/AIMP2, and
p18/AIMP3). A separate complex exists through the association
of ValRS and elongation factor-1H (Motorin et al., 1987). The
AARSs that are not contained in these two complexes are mostly
freestanding. Formation of the MSC has been proposed to have
a functional dualism: both facilitating protein synthesis by direct
channeling of aminoacylated tRNA to the ribosome (Sivaram and
Deutscher, 1990) and serving as a reservoir of various regulatory
functions associated with its synthetase and nonsynthetase
components (Lee et al., 2004; Ray et al., 2007). Not surprisingly,0, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1093
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Perspectiveacquisition of the new domains is also critical for the assembly of
the MSC (Rho et al., 1999).
New Domains Are often Associated with or near
Structural Disorders
Most of the structural information on AARSs has been derived
from crystal structure analyses. From those analyses, it is clear
that the new domains and motifs of AARSs are often disordered
or linked to the conserved enzymatic core via a disordered linker.
The first example is found in human TyrRS. Despite tremendous
efforts, the protein could not be crystallized without chopping off
a C-terminal extension added to TyrRS from insects to human.
The structure of the enzyme core—mini-TyrRS—was solved at
1.18 A˚, which is the highest resolution achieved for a tRNA syn-
thetase (Yang et al., 2002). The C-terminal extension itself,
named EMAP-II-like domain for its high homology to a human
cytokine (endothelial monocyte activating polypeptide II) that
turns out to be a proteolytic product of MSC p43/AIMP1, can
also be crystallized and exhibits a globular structure (Yang
et al., 2003a). Therefore, a conformational flexibility might be
introduced by the way that the EMAP-II-like domain is joined
to the core enzyme that makes crystallization of the full-length
protein difficult. Indeed, 22 residues (D343–I364) between the
enzyme core and the EMAP-II-like domain were disordered in
the crystal structure of mini-TyrRS (Yang et al., 2002).
TrpRS is the closest homolog of TyrRS and provides another
example for a disordered linker between the enzyme core and
an appended domain. From fish to humans, TrpRS possesses
a N-terminal extension named WHEP domain. Crystals were
able to grow with the full-length human TrpRS but the helix-
turn-helix WHEP domain was only resolved in one of two sub-
units of the dimeric protein structure (Yang et al., 2003b). The
WHEP domain was asymmetrically resolved because of the
half-of-the-sites binding of Trp-AMP in the same subunit to
help engage the WHEP domain. However, even in the subunit
where the WHEP domain was resolved, 21 residues (D61–E81)
in the linker region between the WHEP domain and the enzyme
core were disordered.
Structural disordering has also been observed within the
appended domains of AARSs. Human LysRS contains a
eukaryote-specific N-terminal extension. Nuclear magnetic
resonance (NMR) studies in solution revealed that the extension
is mostly unstructured (Liu et al., 2012). Consistently, LysRS can
be crystallized only when this extension was removed (Guo et al.,
2008). As another example, the C-terminal vertebrate-specific
UNE-S domain is completely disordered in the crystal structure
of human SerRS (Xu et al., 2012a). The N-terminal WHEP
domains of GlyRS and HisRS were also missing from the elec-
tron density maps, and at least for GlyRS, the WHEP domain is
disordered regardless of the space group in which the proteinFigure 1. Classification of Human Cytoplasmic AARSs Based on Their
(A–C) Structural disorder in new domain (A), structural disorder in linker region (B)
disorders predicted by metaPrDOS are labeled as red bars on top of the domain
disorder that is longer than 20 residues, or a group of shorter disordered stretches
HisRS. Arrows and asterisks indicate protease cleavage and phosphorylation si
NMR analyses are shown to validate the structural disorder prediction results (L
HisRS, PDB 4G84; and PheRS, PDB 3L4G). The TyrRS structure is modeled ba
domain (PDB 1NTG). WHEP domains in GlyRS and HisRS and in one subunit of Tr
by modeling.
Chemistry & Biology 2is crystallized and whether it is in complex with Gly-AMP or other
ligands (Guo et al., 2009).
Classification of Human tRNA Synthetases Based on
Structural Disorders
When a domain is disordered in the crystal structure, it is not
immediately obvious whether the domain is intrinsically unstruc-
tured or the disorder is a result of a flexible linker. In this case,
other complementary methods are needed for clarification. For
example, although the WHEP domain in human HisRS is
completely disordered in the crystal structure (Xu et al.,
2012b), it exhibits the expected helix-turn-helix conformation in
solution as detected with NMR (Protein Data Bank [PDB]
accession 1X59). This suggests that the WHEP domain is essen-
tially structured but adopts multiple conformations relative to
the enzyme core and therefore is missing from the electron
density map.
Theoretically, this ambiguity can also be clarified with bioinfor-
matics approaches because structural disorder is an intrinsic
property encoded by the amino acid sequences of a protein.
Amino acids can be grouped into three classes: order-promoting
residues C, W, Y, I, F, V, L, and probably H, T, and N; disorder-
promoting residues E, P, Q, S, R, K, M, and probably D; and
neutral residues A and G (Radivojac et al., 2007). Clearly, bulky
hydrophobic residues promote order, whereas polar and
charged residues have the opposite effect. Other distinct prop-
erties of disordered regions, such as richness in proline residues
and low sequence complexity, have also been identified and
incorporated into various algorithms to predict the presence of
intrinsic disorders in proteins.
To systematically analyze structural disorders in human cyto-
plasmic tRNA synthetases, we used a prediction server meta-
PrDOS (http://prdos.hgc.jp/meta) based on a meta approach
that integrates the results of seven different predication methods
(Ishida and Kinoshita, 2008). Remarkably, the results are consis-
tent with what we have learned from crystal and NMR structural
analysis (Figure 1). For example, with a 5% false-positive rate,
the server predicted that 26 residues (A337–E362) in the linker
region between the TyrRS enzyme core and the EMAP-II-like
domain are intrinsically disordered. The server also predicted
that 32 residues (A54–V85) in the linker region between the
TrpRS enzyme core and theWHEP domain, the entire N-terminal
extension (M1–V71) of LysRS, and the C-terminal UNE-S
domain (A474–A514) of SerRS to be structurally disordered.
The WHEP domains of GlyRS and HisRS are predicted to be
partially disordered, each having two internal stretches of
ordered region corresponding to the two helices of the helix-
turn-helix motif. Yet, not all new domains are disordered or
near a disordered linker. Based on the prediction, the 20
cytoplasmic human tRNA synthetases can be categorized intoPropensities for Structural Disorder
, and no structural disorder in or near the new domain (C). Significant structural
structures of each AARS. A significant structural disorder refers to a stretch of
that are near each other, such as those seen in theWHEP domain of GlyRS and
tes, respectively. Structures of human AARSs obtained by crystal structure or
ysRS, PDB 3BJU; SerRS, PDB 3VBB; TrpRS, PDB 1R6T; GlyRS, PDB 2ZT5;
sed on the crystal structures of mini-TyrRS (PDB 1N3L) and the EMAP-II-like
pRS were disordered in their respective crystal structures and are also created
0, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1095
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linker regions; and (3) having no significant structural disorder
associated with new domains or linkers (Figure 1). The classifica-
tion and further analyses provide insights into the role of struc-
tural disorders in AARSs.
Structural Disorders in New Domains
Five AARSs (i.e., LysRS, AspRS, SerRS, ThrRS, and CysRS)
exhibit significant structural disorders that are exclusively asso-
ciated with their appended domains (Figure 1A). The majority of
the new domains within this group, including the N-terminal
extensions of LysRS, AspRS, and ThrRS and the C-terminal
extension of CysRS, started to appear in basal eukaryotes and
were documented to exhibit tRNA binding or recognition capac-
ities (Francin et al., 2002). As exemplified by the N-terminal
extension of LysRS (see below), such capacities are likely to
be expanded or diverted to mediate interactions with other
partners in higher eukaryotes.
Among the five AARSs of this group, LysRS and AspRS are
components of MSC. While new domains are often involved in
MSC assembly, the N-terminal extensions of LysRS and AspRS
are the exceptions: both LysRS and AspRS interact with p38/
AIMP2 in the MSC via their enzyme cores (Ofir-Birin et al.,
2013; Robinson et al., 2000). The structurally disordered
N-terminal extension of LysRS instead interacts with other pro-
tein partners both inside and outside the MSC. Inside the
MSC, it interacts with p38 MAP kinase to become phosphory-
lated at Thr52, which triggers its release fromMSC. The released
LysRS is translocated to the plasma membrane to interact with
the transmembrane region of 67LR laminin receptor to enhance
laminin-induced cancer cell migration (Kim et al., 2012).
Although the exact binding site of 67LR on LysRS is not yet
defined, the interaction involves the N-terminal region of LysRS
that includes the N-terminal extension.
SerRS provided the first example illustrating that the regula-
tory function of a tRNA synthetase could be essential (Kawahara
and Stainier, 2009). Three independent forward genetics studies
in zebrafish established that SerRS plays a critical role in
vascular development, and this role is independent of aminoacy-
lation but dependent on the presence the UNE-S domain
appended to vertebrate SerRS from fish to humans (Xu et al.,
2012a). UNE-S contains a robust nuclear localization signal
sequence that directs SerRS into the nucleus to regulate VEGF
expression. Presumably, UNE-S interacts with a specific impor-
tin for mediating the nuclear import and the flexible conformation
of the disordered UNE-S is essential for this interaction. In fact, a
point mutation (F383V) in SerRS linked to abnormal vasculature
disrupts SerRS nuclear localization by sequestering the UNE-S
domain (Xu et al., 2012a).
Structural Disorders in the Linker Region
Significant structural disordering is also found in ten other
AARSs (i.e., GlyRS, HisRS, TyrRS, TrpRS, GlnRS, AsnRS,
MetRS, ValRS, and GluProRS). Compared to the unstructured
N-terminal extension of LysRS and UNE-S domain of SerRS in
the last group, the appended domains within this group have a
preformed structure and are linked to the enzyme cores via
structurally disordered linkers of various lengths (Figure 1B).
The unstructured linkers are used as cleavage sites for prote-
olysis-based activation of the regulatory functions of TyrRS and
TrpRS. Human TyrRS can be secreted and its regulatory func-1096 Chemistry & Biology 20, September 19, 2013 ª2013 Elsevier Lttions outside the cell are self-inhibited until the EMAP-II-like
domain is removed through proteolysis. While the EMAP-II-like
domain itself exhibits cytokine functions similar to those of
EMAP-II, mini-TyrRS manifests IL-8-like pro-inflammatory and
pro-angiogenic cytokine activities through binding to chemokine
receptors CXCR1 and CXCR2 (Vo et al., 2011; Wakasugi and
Schimmel, 1999). Apparently, linking the two functional entities
with a flexible linker facilitates the activation due to the increased
sensitivity of a flexible linker to protease cleavage.
TrpRS is highly upregulated by interferon-g. The upregulation
promotes both secretion and nuclear localization of TrpRS.
When secreted, TrpRS possesses anti-angiogenic activities by
inhibiting VE-cadherin to form cell-cell junction of endothelial
cells (Tzima et al., 2005). Similar to TyrRS, the anti-angiogenic
activity of TrpRS is self-inhibitory until the WHEP domain is
removed to expose the TrpRS active site for binding to VE-
cadherin through its protruding Trp side chains (Zhou et al.,
2010). Here again, the activation of the anti-angiogenic activity
of TrpRS is associated with proteolytic cleavage at a structurally
disordered linker between the enzyme core and an appended
domain.
The disordered linkers also harbor sites for posttranslational
modification, as exemplified in the bifunctional GluProRS. The
protein is linked together via five long disordered regions (36,
47, 33, 40, and 68 residues) that joins the N-terminal GST
domain; the GluRS core; the first, second, and third WHEP
domains; and the C-terminal ProRS core (Figure 1B). Upon inter-
feron-g stimulation, the protein is phosphorylated at Ser886
between the second and third WHEP domains, and at Ser999
between the third WHEP domain and the C-terminal ProRS.
The phosphorylation events triggers the release of GluProRS
from theMSC and the subsequent assembly of theGAIT (g-inter-
feron-activated inhibitor of translation) complex that includes
GluProRS and three other proteins (ribosomal protein L13a,
NS1-associated protein-1, and glyceraldehyde-3-phosphate
dehydrogenase), resulting in translational silencing of VEGF
expression (Arif et al., 2009).
Intriguingly, GlnRS and MetRS are also components of the
MSC, and ValRS exists in association with elongation factor-
1H (Motorin et al., 1987). Each appended domain in GlnRS,
MetRS, and ValRS is linked to its respective enzyme core via a
long and disordered linker (Figure 1B). Possibly, these linkers
are also targeted for posttranslational modifications to trigger
the dissociation of the synthetases from the MSC (or from the
elongation factor) to participate in other regulatory processes.
A disordered region of 23 residues (R72–N94) in between the
eukaryote-specific N-terminal domain (UNE-N) and the human
AsnRS core is predicted bymetaPrDOS. Similar structural disor-
dering in a parasitic AsnRS (Brugia malayi) was revealed with
NMR analysis (Crepin et al., 2011). Interestingly, AsnRS is highly
expressed in Brugia malayi, produced at least ten times more
than any other AARSs and is secreted with the ability to bind
interleukin-8 (IL-8) receptors, CXCR1 and CXCR2, and to
activate their downstream pathways (Ramirez et al., 2006). The
IL-8-like activity of the parasitic AsnRS resides in the UNE-N
domain containing a b-hairpin-a-helix motif also seen in other
CXC cytokines, such as IL-8 and SDF-1(Kron et al., 2012).
Although, in this case, the UNE-N domain does not need to be
cleaved off from the synthetase core to exhibit cytokined All rights reserved
Chemistry & Biology
Perspectiveactivities, the flexibility of the disordered linker may still be
important for ensuring the conformational independence of
UNE-N. Interestingly, human AsnRS does not act on CXCR1
and CXCR2 (Ramirez et al., 2006), but activates another chemo-
kine receptor CCR3 (Howard et al., 2002).
The flexible linkers are also implicated in diseases. The WHEP
domain of HisRS is the main epitope recognized by HisRS
autoantibodies in myositis-interstitial lung disease (Levine
et al., 2007). The disordered linker between the WHEP domain
and the enzyme core harbors a granzyme B cleavage site
(45LGPG48). The cleavage itself and/or the conformational
freedom of the WHEP domain have been implicated in the initia-
tion of the autoimmune disease (Levine et al., 2007). GlyRS also
has aWHEP domain that is flexibly linked to the enzyme core and
its autoantibodies are associated with polymyositis and derma-
tomyositis complicated by interstitial lung disease (Stojanov
et al., 1996). In addition, GlyRS is implicated in Charcot-Marie-
Tooth disease through genetic mutations. As demonstrated for
one Charcot-Marie-Tooth disease-causing mutation (G526R),
the conformation of the WHEP domain is dramatically affected
in the mutant versus WT GlyRS (He et al., 2011).
No Structural Disorder
The appended domains of PheRS, ArgRS, LeuRS, and IleRS do
not exhibit significant structural disorder (Figure 1C). As ex-
pected, no significant structural disorder is found in AlaRS,
which is the only AARS that did not acquire an appended domain
during the course of eukaryotic evolution. The lack of structural
disordering seems to correlate with fewer numbers of regulatory
functions. In fact, only one prominent regulatory function has
been reported for this group of AARSs, which is the critical role
of LeuRS as a leucine sensor for the mTOR-signaling pathway.
Both human and yeast LeuRS activate TORC1 signaling through
a leucine-dependent interaction with Rag GTPase (Bonfils et al.,
2012; Han et al., 2012). However, the interaction is mediated
through different sites on human versus yeast LeuRS, and the
appended domain in human LeuRS (UNE-L) is not responsible
for the interaction.
PheRS is the only human cytoplasmic tRNA synthetase
encoded by two genes, forming a (ab)2 heterotetrameric archi-
tecture. Eukaryotic PheRS-a is longer than its prokaryotic ortho-
logs with a N-terminal extension UNE-F, however eukaryotic
PheRS-b is shorter than its prokaryotic counterparts by the
loss of the anticodon-binding domain B8. The structure of
the N-terminal extension of the a-subunit was well resolved in
the crystal structure of human PheRS to fold into three contin-
uous DNA-binding fold domains and was predicted by structural
modeling to interact with the D, T loops and the anticodon stem
of the cognate tRNA (Finarov et al., 2010). Consistently, trunca-
tion of the DNA-binding fold domains resulted in complete loss of
tRNA aminoacylation while the activation of phenylalanine was
not affected. Therefore, the role of UNE-F in PheRS-a is to
compensate the loss of B8 domain in PheRS-b and is distinct
from regulatory functions discussed here.
It is worth noting that ArgRS, LeuRS, and IleRS are compo-
nents of the MSC, and the UNE-L domain of LeuRS interacts
with both the leucine zipper domain of ArgRS and the UNE-I
domain of IleRS in the MSC (Ling et al., 2005; Rho et al., 1999).
Other appended domains important for the MSC assembly,
such as the GST domains of MetRS and GluProRS, also haveChemistry & Biology 2pre-formed structures. In contrast, the disordered appended
domain of LysRS and AspRS are not involved in MSC assembly.
Therefore, it seems that the assembly of MSC mainly involves
appended domains that are well structured, while the unstruc-
tured regions within the MSC play an important role in regulating
the release of AARSs from the MSC and in mediating their regu-
latory functions outside the MSC.
Functional Significance of Structural Disorders in
AARSs
From the previous analysis, the role of structural disordering in
developing the regulatory functions of AARSs is summarized in
the following aspects.
Regulate the Release from MSC
As exemplified by GluProRS and LysRS, release of the tRNA
synthetase components from its cellular ‘‘depot’’ (MSC) is regu-
lated by posttranslational modifications (i.e., phosphorylation) on
structurally disordered regions. Although phosphorylation can
also act on side chains within structured regions of tRNA synthe-
tases (Kwon et al., 2011; Ofir-Birin et al., 2013), a disordered
region can more easily fold onto the modifying enzyme to facili-
tate substrate binding and to provide more efficient regulations
(Iakoucheva et al., 2004).
Regulate the Activation of Regulatory Functions
As for the same reason that structurally disordered regions
provide better substrate display for posttranslational modifica-
tions, the disordered regions provide enhanced susceptibility
for proteolysis cleavage. As shown by the examples of TyrRS
and TrpRS, such cleavage is critical for the activation of other-
wise masked regulatory functions of AARSs. In addition, the
conformational advantage of an internally disordered region
could dominate distinct sequence specificities associated with
different proteases to provide a unifying mechanism that con-
verges various signaling pathways into the activation of a regula-
tory function of AARS. Indeed, proteaseswith different sequence
specificities can cleave off the EMAP-II-like domain to activate
the regulatory functions of TyrRS (Yang et al., 2007).
Ensure Conformational Independence of the New
Domains and Potentially Coordinate Regulation with
Translation
In addition to their sensitivity to proteolysis-based regulations, a
flexible linker allows the connecting domains to have the confor-
mational freedom to recruit their own binding partners. In the
context of AARS where a new regulatory domain is attached to
an essential component of the translation machinery, this pro-
vides a potential coordination between regulation and transla-
tion. The concept, in some sense, is relevant to the regulatory
function of TrpRS in the nucleus (Sajish et al., 2012). In this
case, the WHEP domain of TrpRS binds to DNA-PK and
PARP-1 and bridges the two proteins for p53 activation. How-
ever, if Trp-AMP is bound to the TrpRS enzyme core, it induces
a large conformational change of the WHEP domain that abol-
ishes its ability to bind to DNA-PK and PARP-1. Therefore, the
flexible linker not only allows the WHEP domain to freely interact
with the large-sized DNA-PK and PARP-1 to activate p53 when
the enzyme core is not in use, but also makes it possible for
Trp-AMP, an aminoacylation reaction intermediate, to induce a
large-scale interdomain conformational change that controls
the nuclear function of TrpRS.0, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1097
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Low Affinity
The N-terminal extension of human LysRS demonstrates the
adaptability of a disordered region to different interaction
partners from tRNA toMAP kinase and to 67LR laminin receptor.
With multiple interaction partners, specificity is a question.
Interaction with a disordered partner has the advantage of high
specificity that is rendered by the induced-fit mechanism. For
example, tRNA interaction induces part of the N-terminal exten-
sion of LysRS (S19–E45) to adopt a helical structure that aligns
positively charged residues on one side of the helix to enhance
the specificity (Guo et al., 2010b; Liu et al., 2012).
The high specificity interaction with a disordered partner is
coupled with low affinity resulting from the large entropy penalty
paid for the disorder-to-order transition (Wright and Dyson,
2009). The combination of high specificity with low affinity is
widely exploited in regulatory processes and is required for
cargo transportation. This could be the reason that the UNE-S
domain of SerRS and the C-terminal region of LysRS (K574–
V597), both of which harbor a nuclear localization signal
sequence, are completely disordered.
Conclusions
Although the importance of intrinsic disorder has been broadly
recognized in cell signaling and regulatory processes (Ward
et al., 2004), its role in expanding the functionome of tRNA syn-
thetases has not been recognized. It is clear that structural disor-
dering is essential to every aspect of the functional expansion,
and the majority of the AARS regulatory functions involve disor-
dered structures in one way or another. Evolutionarily speaking,
because of their smaller numbers of structural constraints, intrin-
sically disordered regions are capable of fast development of
different functions (Rezaei-Ghaleh et al., 2012). This explains, at
least in part, the association of structural disordering with the ex-
tra-aminoacylation functions of AARS and, in turn, suggests that
identifying and understanding structurally disordered regionswill
guide the discovery of more regulatory functions of AARS.
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